Trial · NCT02558400
Adverse events114
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 114
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Conjunctival Hyperaemia | Eye disorders | PG324 Ophthalmic Solution | 133 | 238 | 133 |
| other | Conjunctival Hyperaemia | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 115 | 243 | 115 |
| other | Conjunctival Hyperaemia | Eye disorders | Latanoprost Ophthalmic Solution 0.005% | 44 | 237 | 44 |
| other | Cornea Verticillata | Eye disorders | PG324 Ophthalmic Solution | 39 | 238 | 39 |
| other | Cornea Verticillata | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 32 | 243 | 32 |
| other | Cornea Verticillata | Eye disorders | Latanoprost Ophthalmic Solution 0.005% | 0 | 237 | 0 |
| other | Eye Pruritus | Eye disorders | PG324 Ophthalmic Solution | 20 | 238 | 20 |
| other | Eye Pruritus | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 20 | 243 | 20 |
| other | Eye Pruritus | Eye disorders | Latanoprost Ophthalmic Solution 0.005% | 2 | 237 | 2 |
| other | Lacrimation Increased | Eye disorders | PG324 Ophthalmic Solution | 15 | 238 | 15 |
| other | Lacrimation Increased | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 17 | 243 | 17 |
| other | Lacrimation Increased | Eye disorders | Latanoprost Ophthalmic Solution 0.005% | 1 | 237 | 1 |
| other | Conjunctival Haemorrhage | Eye disorders | PG324 Ophthalmic Solution | 10 | 238 | 10 |
| other | Conjunctival Haemorrhage | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 14 | 243 | 14 |
| other | Conjunctival Haemorrhage | Eye disorders | Latanoprost Ophthalmic Solution 0.005% | 2 | 237 | 2 |
| other | Punctate Keratitis | Eye disorders | PG324 Ophthalmic Solution | 9 | 238 | 9 |
| other | Punctate Keratitis | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 13 | 243 | 13 |
| other | Punctate Keratitis | Eye disorders | Latanoprost Ophthalmic Solution 0.005% | 4 | 237 | 4 |
| other | Vision Blurred | Eye disorders | PG324 Ophthalmic Solution | 9 | 238 | 9 |
| other | Vision Blurred | Eye disorders | AR-13324 Ophthalmic Solution 0.02% | 14 | 243 | 14 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02558400/events